Females also had slightly higher reporting odds of ICANS (ROR = 1.06, N = 943/4775 males and 602/2925 females), although it did not reach statistical significance (Fig. 3a and Supplementary Fig. 1 ).
← all excerpts
A retrospective pharmacovigilance analysis based on the FAERS database reveals sex-associated differences in toxicities of CAR T-cell therapy.
1
—
—